Fenbendazole is a medication originally used to deworm animals, but multiple peer-reviewed studies have shown it can also fight many harmful cancers in humans. It is important to work with a health care professional while using this protocol to make sure the proper dosage is taken and other supplements are used that are safe to take in combination with fenbendazole.
In cancer cells, fenbendazole interferes with glucose intake, starving the cells of their main source of energy. This results in a decrease in cell growth and apoptosis in both laboratory settings and live subjects.
The drug works by binding to tubulin microtubules and disrupting their formation. The binding affects all helminths but is specific to those in the intestine, which is where most of the drug is absorbed. Several studies have tested the drug on pancreatic cancer, and early findings show it is potentially beneficial.
However, more rigorous research is needed to test fenbendazole for human clinical trials. These trials would determine the correct dosage and treatment regimen, compare its success to standard treatments for pancreatic cancer, and assess safety. Until such trials are conducted, the medication is only available for use in animal and lab settings. In addition, patients interested in trying this protocol should be aware of the detoxification effects that can occur while taking fenbendazole for cancer, including flu-like symptoms, nausea, body aches, and sweating. These side effects are normal and indicate the medicine is working to kill pathogens in the body. fenbendazole for humans